Indonesian Political, Business & Finance News

Phapros mitigates impact of rupiah weakening on raw material costs

| Source: Antara (Indonesian) Translated from Indonesian | Business
Phapros mitigates impact of rupiah weakening on raw material costs
Image: Antara (Indonesian)

Jakarta (ANTARA) - The state-owned pharmaceutical company and subsidiary of PT Kimia Farme Tbk, PT Phapros Tbk, is undertaking several mitigation steps to suppress the impact of the rupiah’s weakening trend against the US dollar on imported raw material costs and company operations.

“Given that the fluctuation of the rupiah exchange rate is an external factor, Phapros will focus more on internal measures since we cannot control it. Therefore, what we are striving to control is mitigation to minimise the negative impacts,” said Phapros Production Director Ida Rahmi Kurniasih during the company’s Public Expose following the 2025 Annual General Meeting of Shareholders (RUPST) in Jakarta on Thursday.

The rupiah exchange rate at the close of Thursday afternoon weakened by 45 points or 0.25 per cent to Rp17,989 per US dollar from the previous Rp17,944 per US dollar.

Ida stated that the trend of rupiah depreciation has impacted the increase in raw material and shipping costs for the pharmaceutical industry, which remains dependent on imports.

According to her, the company has prepared several mitigation steps, including developing scenarios for the rupiah’s weakening against the US dollar, renegotiating prices with overseas suppliers, and diversifying raw material sources.

Additionally, the company is considering the use of currencies other than the US dollar in raw material import transactions.

“We continue to seek alternative raw materials to obtain better prices, including the possibility of conducting transactions in currencies other than the US dollar. For example, we have now begun purchasing some materials in renminbi (Chinese yuan) and euro,” said Ida.

She added that the company is also preparing earlier raw material procurement contracts with longer durations to maintain price stability and supply continuity.

In addition to implementing cross-divisional efficiencies, Phaproc is also preparing hedging measures to minimise the impact of exchange rate fluctuations on company operations.

Phapros President Director Intan Abdams Katoppo stated that the national pharmaceutical industry still faces the challenge of high import dependency for raw materials, which reaches over 90 per cent.

However, according to her, the growing demand for healthcare services and the National Health Insurance (JKN) programme continue to present growth opportunities for the domestic pharmaceutical industry.

In 2026, the company is also preparing to expand its export markets to Timor-Leste, Cambodia, the Philippines, Myanmar, Papua New Guinea, and Peru to broaden its international presence.

Intan noted that overseas market expansion is being conducted to expand market reach while simultaneously capitalising on the strengthening of the US dollar against the rupiah.

“To capitalise on this momentum of the strengthening dollar, we are encouraging sales to overseas markets such as Timor-Leste, Cambodia, the Philippines, Myanmar, Papua New Guinea, and Peru,” Intan revealed.

In addition to expanding export markets, the company is preparing four new products for 2026, including the children’s multivitamins Vicom Grow and Vicom Star, as well as the antibiotic Pehafosh. These children’s multivitamins are also being prepared to support the government’s stunting reduction programme.

More from 11 June 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/phapros-mitigates-impact-of-rupiah-weakening-on-raw-material-costs-1781190282)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5604591/phapros-lakukan-mitigasi-dampak-pelemahan-rupiah-pada-bahan-baku), translated from Indonesian
Print